Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: A systematic review of disparate risks

Transfusion

Volumn 49, Issue 12, 2009, Pages 2743-2758

  Vamvakas, Eleftherios C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHERESIS; ARTICLE; ATTRIBUTABLE RISK; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONSENSUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; META ANALYSIS; POSTTRANSFUSION HEPATITIS; RISK FACTOR; SEPSIS; SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; TORQUE TENO VIRUS; TRANSFUSION ASSOCIATED SEPSIS; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES; VIRUS TRANSMISSION;

BLOOD COMPONENT REMOVAL; BLOOD DONORS; BLOOD TRANSFUSION; HUMANS; INFECTION; RISK FACTORS; UNITED STATES;

EID: 71849085964     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02338.x     Document Type: Article

References (110)

1. Ness PM, Campbell-Lee SA. Single-donor versus pooled random-donor platelet concentrates. Curr Opin Hematol 2001 8 : 392 6.
2. McDonald CP, Blajchman MA. Bacterial contamination in blood and blood components. In : Barbara JS, Regan FA, Contreras MC, editors. Transfusion microbiology. Cambridge : Cambridge University Press 2008. p. 87 115.
3. Brecher ME, Holland PV, Pineda AA, Tegtmeier GE, Yomtovian R. Growth of bacteria in inoculated platelets: implications for bacterial detection and the extension of platelet storage. Transfusion 2000 40 : 1308 12.
4. Wagner SJ, Maroff G, Katz AJ, Friedman LI. Comparison of bacterial growth in single and pooled platelet concentrates after deliberate inoculation and storage. Transfusion 1995 35 : 298 303.
5. Ness P, Braine N, King K, Barrasso C, Kickler T, Fuller A, Blades N. Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001 41 : 857 61.
6. Robillard P, Nawej KI, Jochem K. The Quebec hemovigilance system: description and results from the first two years. Transfus Apher Sci 2004 31 : 111 22.
7. Whitaker BI, Green J, King MR, Leibeg LL, Sclumpf KS, Schreiber GB. The 2007 Nationwide Blood Collection and Utilization Survey Report. Washington, DC : Department of Health and Human Services 2008.
8. Vamvakas E, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009 113 : 3406 17.
9. FDA/CBER. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2008 cited 2009 Mar 13]. Available from: http://www.fda.gov/cber/blood/fatal08.htm
10. Chapman CE, Stainsby D, Jones D, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009 49 : 440 52.
11. Serious Hazards of Transfusion (SHOT) Annual Reports cited 2009 Mar 13]. Available from: http://www.shot-uk.org
12. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CC, Stroncek D National Heart, Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005 33 : 721 6.
13. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004 44 : 1774 89.
14. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985 25 : 573 7.
15. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 2003 43 : 1053 9.
16. Middleburg RA, van Stein D, Briet E, van der Bom JG. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008 48 : 2167 76.
17. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009 epub ahead of print.
18. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, Mackenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 2003 43 : 177 84.
19. Eder AF, Herron R, Strupp A, Dy B, Notari EP, Chambers LA, Dodd RY, Benjamin RJ. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007 47 : 599 607.
20. Popovsky MA, Chaplin HC Jr., Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion 1992 32 : 589 92.
21. Fadeyi EA, Adams S, Sheldon S, Leitman SF, Wesley R, Klein HG, Stroncek DF. A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leukocyte antigen antibodies. Vox Sang 2008 94 : 324 8.
22. Eastlund T, McGrath PC, Burkart P. Platelet transfusion reaction associated with inter-donor HLA incompatibility. Vox Sang 1988 55 : 157 60.
23. Bux J, Hoch J, Bindl L, Muller A, Muller-Eckhardt C Transfusion- associated acute pulmonary insufficiency. Diagnostic confirmation by the demonstration of granulocytic antibodies Dtsch Med Wochenschr 1994 119 : 19 24 (in German).
24. Ramanathan RK, Triulzi DJ, Logan TF. Transfusion-related acute lung injury following random-donor platelet transfusion: a report of two cases. Vox Sang 1997 73 : 43 5.
25. Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP. How much residual plasma may cause TRALI? Transfus Med 2008 18 : 276 80.
26. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003 101 : 454 62.
27. Strong DM, Shoos LK. Transfusion-related acute lung injury. AABB Association Bulletin #06-07 (November 3, 2006). [cited 2009 Mar 13]. Available from: http://www.aabb.org/Content/Members-Area/Association-Bulletins/
28. Insunza A, Romon I, Gonzalez-Ponte ML, Hoyos A, Pastor JM, Iriondo A, Hermosa V. Implementation of a strategy to prevent TRALI in a regional blood center. Transf Med 2004 14 : 157 64.
29. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic-acid amplification testing. N Engl J Med 2004 351 : 760 8.
30. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, Kleinman SH, Hollingsworth CG, Nemo GJ. Estimates of infectious disease risk factors in US blood donors. JAMA 1997 277 : 967 72.
31. Wang B, Schreiber GB, Glynn SA, Kleinman S, Wright DJ, Murphy EL, Busch MP. Does prevalence of transfusion-transmitted viral infection reflect corresponding incidence in United States blood donors? Transfusion 2005 45 : 1089 96.
32. Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ, Brecher ME. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: fall 2004 impact survey. Transfusion 2006 46 : 636 41.
33. Schrezenmeier H, Walther-Weuke G, Mullter TH, Weinauer F, Younis A, Holland-Letz T, Geis G, Asmus J, Bauerfeind U, Burkhart J, Deitenbeck R, Förstemann E, Gebauer W, Höchsmann B, Karakassopoulos A, Liebscher UM, Sänger W, Schmidt M, Schunter F, Sireis W, Seifried E. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole-blood-derived platelets and apheresis platelets. Transfusion 2007 47 : 644 52.
34. de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006 46 : 476 85.
35. Kleinman SH, Kamel HT, Harpool DR, Vanderpool SK, Custer B, Wiltbank TB, Nguyen KA, Tomasulo PA. Two-year experience with aerobic culturing of apheresis and whole-blood-derived platelets. Transfusion 2006 46 : 1787 94.
36. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J. Six years' experience of using the Bact/ALERT system to screen all platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005 88 : 93 7.
37. Yomtovian RA, Palavecino EL, Dysktra AH, Downes KA, Morrissey AM, Bajaksouzian S, Pokorny MA, Lazarus HM, Jacobs MR. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion 2006 46 : 719 30.
38. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadden E, Coakley P. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternate approach to product safety. Vox Sang 2008 95 : 13 9.
39. Benjamin RJ, Kline L, Dy BA, Kennedy J, Pisciotto P, Sapatnekar S, Mercado R, Eder AF. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 2008 48 : 2348 55.
40. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial co-ordination. Am J Respir Crit Care Med 1994 149 : 818 24. (Pubitemid 24082248)
41. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, Glauser M, Parsons P, Fisher CJ, Repine JE. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a re-evaluation. Crit Care Med 2000 28 : 232 5.
42. Meade MO, Guyatt GH, Cook RJ, Groll R, Kachura JR, Wigg M, Cook DJ, Slutsky AS, Stewart TE. Agreement between alternative classifications of acute respiratory distress syndrome. Am J Respir Crit Care Med 2001 163 : 490 3. (Pubitemid 32158534)
43. Toy P, Gajic O. Transfusion-related acute lung injury. Anesth Analg 2004 99 : 1623 4.
44. Gajic O, Moore SB. Transfusion-related acute lung injury. Mayo Clin Proc 2005 80 : 766 70.
45. Kopko P, Silva M, Shulman I, Kleinman S. AABB survey of transfusion-related acute lung injury policies and practices in the United States. Transfusion 2007 47 : 1679 85.
46. Kopko PM, Marshall CS, Mackenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a look-back investigation. JAMA 2002 287 : 1968 71.
47. Davis A, Mandal R, Johnson M, Makar R, Stowell C, Dzik S. A touch of TRALI. Transfusion 2008 48 : 541 5.
48. Robillard P, Hyson C, McCombie N. TRALI, possible TRALI and respiratory complications of transfusion reported to the Canadian Transfusion-Transmitted Injuries Surveillance System. Transfusion 2007 47 Suppl : 5A.
49. Gajic O, Rana R, Winters JL, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007 176 : 886 91.
50. Gajic O, Rana R, Mendez JL, Rickman OB, Lymp JF, Hubmayr RD, Moore SB. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion 2004 44 : 1468 74.
51. Rana R, Fernandez-Perez ER, Khan SA, Rana S, Winters JL, Lesnick TG, Moore SB, Gajic O. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006 46 : 1478 83.
52. McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara JA. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004 86 : 178 82.
53. Benjamin RJ, Wagner SJ. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007 47 : 1381 9.
54. Schmidt M. Comparison of different methods of bacterial detection in blood components. ISBT Sci Ser 2009 4 : 80 6.
55. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 88.
56. Cooper H, Hedges LV. The handbook of research synthesis. New York : Russell Sage Foundation 1994.
57. Dodd RY, Notari EP 4th., Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002 42 : 975 9.
58. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH. A new strategy for estimating risks of transfusion-transmitted infections based on rates of detection of recently-infected donors. Transfusion 2005 95 : 254 64.
59. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007 131 : 702 7.
60. Kleinman SH, Busch MP. Assessing the impact of HBV NAT on window-period reduction and residual risk. J Clin Virol 2006 36 Suppl : S523 9.
61. Kleinman SH, Strong DM, Tegtmeier GE, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005 45 : 1247 57.
62. Rios M. Climate change and vector-borne viral diseases potentially transmitted by transfusion. ISBT Sci Ser 2009 4 : 87 94.
63. Peterman TA, Lui KJ, Lawrence DN, Allen JR. Estimating the risks of transfusion-associated acquired immune deficiency syndrome and human immunodeficiency virus infection. Transfusion 1987 27 : 371 4.
64. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts - blood transfusion. N Engl J Med 1999 340 : 438 47.
65. Pealer LN, Martin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, Stobierski MG, Signs K, Newman B, Kapoor H, Goodman JL, Chamberland ME. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003 349 : 1236 45.
66. Biggerstaff BJ, Petersen LR. Estimated risk of transmission of West Nile Virus through blood transfusion in the US, 2002. Transfusion 2003 43 : 1007 17.
67. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003 349 : 1205 6.
68. Tambyah PA, Koay ES, Poon ML, Lin RV, Ong BK. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008 359 : 1526 7.
69. Seed CR, Kiely P, Hyland CA, Keller AJ. The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia. Transfusion 2009 49 : 1482 7.
70. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Drottori M, Ciufolini MG, Majori GC, Cassone A. Infection with Chickungunya virus in Italy: an outbreak in a temperate region. Lancet 2007 370 : 1840 6.
71. Schimmer B, Morroy G, Dijkstra F, Schneeberger PM, Weers-Pothoff G, Timen A, Wijkmans C, van der Hoek W. Large on-going Q fever outbreak in the south of the Netherlands, 2008. Euro Surveill 2008 13 : pii=18939. [cited 2009 Mar 13]. Available from: http://www/eurosurveillance.org/ViewArticle.aspx?ArticleId=18939
72. Kilic S, Yilmaz GR, Komiya T, Kurtoglu Y, Karakoc EA. Prevalence of Coxiella burnetii antibodies in blood donors in Ankara, Central Anatolia, Turkey. New Microbiol 2008 31 : 527 34.
73. Chudy M, Schmidt M, Czudai V, Scheiblauer H, Nick S, Mosebach M, Hourfar MK, Seifried E, Roth WK, Grünelt E, Nübling CM. Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology 2006 44 : 99 107.
74. Lopez-Plaza I, Weissfeld J, Triulzi DJ. The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets. Transfusion 1999 39 : 925 32.
75. Heuft HG, Mende W, Blasczyk R. A general change of the platelet transfusion policy from apheresis platelet concentrates to pooled platelet concentrates is associated with a sharp increase in donor exposures and infection rates. Transfus Med Hemother 2008 35 : 106 13.
76. Consensus conference: platelet transfusion therapy. JAMA 1987 257 : 1777 80.
77. Garratty G. Problems associated with passively-transfused blood group alloantibodies. Am J Clin Pathol 1998 109 : 769 77.
78. Klein HG, Anstee DJ. Destruction of recipient's own red cells by transfused anti-A or anti-B. Mollison's blood transfusion in clinical medicine. 11th ed. Malden (MA) : Blackwell Publishing 2005. p. 460 2.
79. Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North-American laboratories. Arch Pathol Lab Med 2007 131 : 909 16.
80. Josephson CD, Mullis NC, van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy. Transfusion 2004 44 : 805 8.
81. Perez P, Sahmi LR, Follea G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM case-control study. Transfusion 2001 41 : 862 72.
82. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001 41 : 1493 9.
83. Ramirez-Arcos S, Jenkins C, Dion J, Bernier F, Dellage G, Goldman M. Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007 47 : 421 9.
84. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007 47 : 1134 42.
85. Uhl L. Alternatives to transfusion: perioperative blood management. In : Simon TL, Snyder EL, Solheim BG, Stowell CP, Strauss RG, Petrides M, editors. Rossi's principles of transfusion medicine. 4th ed. Bethesda (MD) : AABB Press 2009. p. 566 74.
86. Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA. Cell-salvage for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006 4 : 1 109.
87. Murphy W. Managing threats rather than risks in blood transfusion: robust design for a complex system. Transfusion 2006 46 : 2011 3.
88. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007 47 : 238 47.
89. Alter HJ. Pathogen reduction: a precautionary-principle paradigm. Transfus Med Rev 2008 22 : 97 102.
90. Petersen LR, Epstein JS. Problem solved? West Nile Virus and transfusion safety. N Engl J Med 2005 353 : 516 7.
91. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005 105 : 2266 73.
92. Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009 108 : 770 6.
93. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007 136 : 788 99. (Pubitemid 46348408)
94. Kehler MR, Masumo T, Moore EE, Damle S, Meng X, Song Y, Liang X, Niedzinski J, Geier SS, Khan SY, Gamboni-Robertson F, Silliman CC. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood 2009 113 : 2079 87.
95. Silliman CC, Curtis BR, Kopko PM, Schuller RM, Sannoh B, Ambruso DR. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vivo model. Blood 2007 109 : 1752 5.
96. ISBT Working Party on Granulocyte Immunobiology. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leukocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009 96 : 266 9.
97. Reil A, Keller-Stanislawski B, Gunay S, Bux J. Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang 2008 95 : 313 7.
98. Davoren A, Curtis RJ, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a(5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003 43 : 641 5.
99. Lin Y, Kanani N, Naughton F, Pendergrast J, Karkouti K. Case report: transfusion-related acute lung injury (TRALI) - a clear and present danger. Can J Anesth 2007 J4 : 1011 6.
100. Salman SS, Fernandez Perez ER, Stubbs JR, Gajic O. The practice of platelet transfusion in the intensive care unit. J Int Care Med 2007 22 : 105 10.
101. Kleinman S, Dumont LJ, Tomasulo P, Bianco C, Katz L, Benjamin RJ, Gajic O, Brecher ME. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments. Transfusion 2009 49 : 903 12.
102. Hume HA. TRALI: moving toward prevention. Transfusion 2009 49 : 402 5.
103. Wright SE, Snowden CP, Athey SC, Leaver AA, Clarkson JM, Chapman CE, Roberts DR, Wallis JP. Acute lung injury after abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh-frozen plasma. Crit Care Med 2008 36 : 1796 802.
104. Benjamin RJ, Roggeveen B, Reeves C, Kelly ME. TRALI: components from female donors are not disproportionately involved in common transfusion reactions. Transfusion 2004 44 Suppl : 34A.
105. Brumit MC, Welsby I, Phillips-Bute B, Ramsey R, Lin S, Boyd T, Stafford-Smith M. Relationship between FFP donor gender and outcome in 2,157 transfused cardiac surgery patients. Transfusion 2007 47 Suppl : 6A.
106. Middleburg RA, van Stein D, Zupanska B, Uhrynowska M, Gajic O, Silliman CC, Reil A, Bux J, Wallis J, Briet E, Van der Bom JG. Inconsistent association between donor gender and clinically-defined TRALI. Vox Sang 2008 95 Suppl 1 : 165.
107. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for non-bleeding patients in the intensive-care unit: benefit or harm? Crit Care Med 2006 34 Suppl 5 : S170 3.
108. Silliman CC. High-volume transfusion from male-only versus female donor plasma and hypoxemia in the critically ill. Crit Care Med 2007 35 : 1775.
109. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003 : 575 89.
110. Mohr H, Bayer A, Gravemann U, Muller TH. Elimination and multiplication of bacteria during preparation and storage of buffy-coat-derived platelet concentrates. Transfusion 2006 46 : 949 55.